Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

NCT05181891 is registered in ClinicalTrials.gov with Washington State University as lead sponsor.

NCT NCT05181891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05181891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Lead sponsor
Washington State University
Phase
Phase 2
Overall status
Recruiting
Start date
July 11, 2022
Completion date
May 1, 2027
Enrollment
205 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud), nicotine use disorder